MedTrace Logo

Retrospective Study in Sarcoma Patients

NCT03284320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 514

Last updated 2021-11-15

No results posted yet for this study

Summary

The objectives of this trial is to evaluate efficacy and safety of treatment with Trabectedin in a large cohort of German patients with soft tissue and bone sarcomas.

Conditions

  • Sarcoma of Bone
  • Sarcoma of Soft Tissue

Sponsors & Collaborators

  • PharmaMar

    collaborator INDUSTRY

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Daniel Pink, MD · University Medicine Greifswald

  • Peter Reichardt, MD · Sarcoma Center Berlin-Brandenburg; HELIOS Hospital Berlin Buch

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-18
Primary Completion
2019-12-31
Completion
2021-11-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03284320 on ClinicalTrials.gov